Dave Kappos Speaks at IAM Connect’s SEP Summit 2023
September 20, 2023
On September 19, 2023, Cravath partner David J. Kappos participated in IAM Connect’s SEP Summit 2023, which was held virtually from September 19‑21, 2023. Dave spoke on a panel entitled “The game‑changing European SEP/FRAND draft regulation,” which reviewed the potential impacts of a recent policy proposed in Brussels to create a SEP royalty rate setting body in Europe’s trademark office, including the practical impact on licensors in Europe, how SEP owners will need to adapt and implications for global SEP strategy.
Related Practices & Industries
Speakers
- Photo
-
-
J.D., 1990, University of California, Berkeley, School of Law
-
B.S., 1983, University of California, Davissumma cum laude
- New York
- California
- District of Columbia
Education
Admitted In
Related News & Insights
Deals & Cases
August 15, 2023
DRI Healthcare Trust’s Acquisition of a Second Royalty Interest in the Worldwide Sales of ORSERDU®
On August 14, 2023, DRI Healthcare Trust, a global leader in providing financing to advance innovation in the life sciences industry, managed by DRI Capital Inc., announced that it has purchased a second royalty interest in the worldwide net sales of ORSERDU®, the first approved targeted therapy used in the treatment of postmenopausal women or adult men with advanced or metastatic breast cancer who have experienced disease progression despite prior endocrine therapy. DRI Healthcare entered into a purchase agreement with Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. for an upfront purchase price of $130 million. In addition to running royalties, DRI Healthcare is also entitled to receive milestone payments of up to $40 million on the achievement of sales performance thresholds. Cravath represented DRI Capital Inc. in connection with the transaction.
Deals & Cases
August 08, 2023
EchoStar Corporation’s $6 Billion Combination with DISH Network Corporation
On August 8, 2023, EchoStar Corporation and DISH Network Corporation (“DISH Network”) announced they have entered into a definitive agreement for DISH Network to combine with EchoStar Corporation in an approximately $6 billion all-stock merger. Cravath is representing the Special Committee of the Board of Directors of EchoStar Corporation in connection with the transaction.
Deals & Cases
August 04, 2023
Hasbro’s Sale of its eOne Film and TV Business to Lionsgate
On August 3, 2023, Hasbro, Inc., a leading toy and game company, announced that it has reached a definitive agreement to sell its eOne film and TV business to Lionsgate for approximately $500 million, consisting of $375 million in cash, subject to certain purchase price adjustments, and the assumption by Lionsgate of production financing loans. Cravath is representing Hasbro in connection with the transaction.
Deals & Cases
July 28, 2023
Biogen’s $7.3 Billion Acquisition of Reata Pharmaceuticals
On July 28, 2023, Biogen Inc. (“Biogen”) and Reata Pharmaceuticals, Inc. (“Reata”) announced that they have entered into a definitive agreement under which Biogen has agreed to acquire Reata for $172.50 per share in cash, reflecting an enterprise value of approximately $7.3 billion. Cravath is representing Biogen in connection with the transaction.
